This article is sponsored by Cytiva
Cytiva is a global provider of technologies and services that advance and accelerate the development, manufacture, and delivery of therapeutics. Its customers undertake activities ranging from biological research to developing innovative vaccines, biologic drugs, and novel cell and gene therapies.
In this interview, Katarina Stenklo, Enterprise Solutions Commercial Activation leader at Cytiva discusses her company's product FlexFactory and how there has been over 100 installations. She also explains how this technology will impact the future and what the next five years looks like.
Stenklo: "We have seen the speed of how quickly vaccines were developed, so expect faster to-market times and the concept of having more standardised modules."
Manufacturing Chemist in conversation with...
'Manufacturing Chemist in conversation with' is a series of exclusive video interviews with leading companies in the cleanroom industry, conducted by our team of B2B journalists.
For more information on how you can be part of 'Manufacturing Chemist in conversation with' contact Don Phares via don@hpcimedia.com or +44 (0) 207 193 3219.
This interview was led by Tom McGhie from Manufacturing Chemist.
